Nxera Pharma Notes Successful Development Progress of
NBI-1117568 is an oral, selective muscarinic M4 receptor agonist advancing through Phase 2 clinical development under a multi-program collaboration with ...
Read moreNBI-1117568 is an oral, selective muscarinic M4 receptor agonist advancing through Phase 2 clinical development under a multi-program collaboration with ...
Read moreTARRYTOWN, New York, April 11, 2024 (GLOBE NEWSWIRE) -- via IBN – PaxMedica, Inc. (NASDAQ:PXMD), a biopharmaceutical company focused on ...
Read more05 April 2024 - Ahead of International Day of Sport for Development and Peace (IDSDP) on 6 April, as the ...
Read moreParticipants discuss Korea-Africa private sector cooperation and action plans for energy transition, critical minerals and infrastructureInvestment and cooperation opportunities are ...
Read moreThe Government of India’s Ministry of Rural Development (MoRD) has brought the Abdul Latif Jameel Poverty Action Lab (J-PAL) ...
Read moreParticipants discuss Korea-Africa private sector cooperation and action plans for energy transition, critical minerals and infrastructureInvestment and cooperation opportunities are ...
Read moreBest Agrolife Limited (BAL), a prominent leader in the agricultural solutions sector, has proudly secured the prestigious "Most Innovative ...
Read moreOn behalf of ACHEMA, the world forum and leading show for the process industries, The Indo-German Chamber of Commerce ...
Read morePancham Dham, a sacred haven of spirituality and enlightenment, successfully concluded the Pancham Dham Conclave that took place from ...
Read moreIn a major development in high-capacity harvesting set to help large farms gather their crops more efficiently and more sustainably, ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.